Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1964 1
1966 1
1970 1
1971 1
1972 1
1973 2
1976 7
1977 4
1978 1
1979 2
1980 4
1981 2
1982 2
1983 1
1984 5
1985 3
1986 6
1987 3
1988 8
1989 11
1990 9
1991 8
1992 8
1993 7
1994 5
1995 8
1996 11
1997 11
1998 11
1999 13
2000 12
2001 10
2002 16
2003 13
2004 9
2005 8
2006 16
2007 11
2008 16
2009 11
2010 16
2011 14
2012 12
2013 17
2014 14
2015 8
2016 16
2017 13
2018 14
2019 10
2020 14
2021 18
2022 14
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Apocrine lesions of the breast.
Quinn CM, D'Arcy C, Wells C. Quinn CM, et al. Virchows Arch. 2022 Jan;480(1):177-189. doi: 10.1007/s00428-021-03185-4. Epub 2021 Sep 18. Virchows Arch. 2022. PMID: 34537861 Free PMC article. Review.
Breast Carcinoma: Updates in Molecular Profiling 2018.
Bandyopadhyay S, Bluth MH, Ali-Fehmi R. Bandyopadhyay S, et al. Clin Lab Med. 2018 Jun;38(2):401-420. doi: 10.1016/j.cll.2018.02.006. Clin Lab Med. 2018. PMID: 29776638 Review.
Understanding the progression pathways involved in the transition of in situ carcinoma to invasive carcinoma might lead to efficient risk stratification in these patients. ...
Understanding the progression pathways involved in the transition of in situ carcinoma to invasive carcinoma might lead …
Avoiding "False Positive" and "False Negative" Immunohistochemical Results in Breast Pathology.
Li Z, Dabbs DJ. Li Z, et al. Pathobiology. 2022;89(5):309-323. doi: 10.1159/000521682. Epub 2022 Mar 4. Pathobiology. 2022. PMID: 35249034 Free article. Review.
This review intends to focus on the challenging areas such as the interpretation of myoepithelial cell markers in differentiating benign proliferation and in situ carcinoma from invasive carcinoma, lobular cell markers in differentiating lobular from ductal c …
This review intends to focus on the challenging areas such as the interpretation of myoepithelial cell markers in differentiating benign pro …
Diagnostic challenges in papillary lesions of the breast.
Rakha EA, Ellis IO. Rakha EA, et al. Pathology. 2018 Jan;50(1):100-110. doi: 10.1016/j.pathol.2017.10.005. Epub 2017 Nov 26. Pathology. 2018. PMID: 29179906 Review.
Identification of low nuclear grade atypia within benign papillary lesions and its classification into atypia or in situ carcinoma may also pose a diagnostic challenge. Although immunohistochemistry is helpful in evaluation of benign and atypical lesions it h …
Identification of low nuclear grade atypia within benign papillary lesions and its classification into atypia or in situ ca …
Opinion: Comment on Evaluation and Treatment of Cryptorchidism: AUA/AAP and Nordic Consensus Guidelines.
Hadziselimovic F. Hadziselimovic F. Urol Int. 2016;96(3):249-54. doi: 10.1159/000443741. Epub 2016 Jan 30. Urol Int. 2016. PMID: 26824668 Free article. Review.
Testicular biopsy is all the more justified that it allowed the detection of in situ carcinoma in 0.6% of all the cryptorchid boys studied. Even if hormonal pre-treatment only achieves successful epididymo-testicular descent in 20% of cases, this treatment sh …
Testicular biopsy is all the more justified that it allowed the detection of in situ carcinoma in 0.6% of all the crypt …
Colorectal endoscopic submucosal dissection: a review on patient selection and indications.
Bronswijk M, Rasschaert G, Hayashi Y, Yamamoto H. Bronswijk M, et al. Acta Gastroenterol Belg. 2023 Jan-Mar;86(1):36-46. doi: 10.51821/86.1.10856. Acta Gastroenterol Belg. 2023. PMID: 36842174 Free article. Review.
ESD should be considered for large colorectal polyps (20mm) and/or lesions diagnosed as harbouring high-grade dysplasia, in-situ carcinoma or superficial submucosal invasion. Not only has it found its way into our guidelines for the treatment of neuroendocrin …
ESD should be considered for large colorectal polyps (20mm) and/or lesions diagnosed as harbouring high-grade dysplasia, in-situ …
Primary squamous cell carcinoma of the ovary. Review of the literature.
Koufopoulos N, Nasi D, Goudeli C, Antoniadou F, Kokkali S, Pigadioti E, Provatas I, Maggo E, Ardavanis A, Terzakis E, Arkoumani E, J Agnantis N, Apostolikas N, Khaldi L. Koufopoulos N, et al. J BUON. 2019 Sep-Oct;24(5):1776-1784. J BUON. 2019. PMID: 31786837 Free article. Review.
Nine patients had stage I, 8 stage II, 11 stage III and 5 stage IV disease, whereas 3 patients had in situ carcinoma. All patients underwent surgery (mainly hysterectomy with bilateral salpingo-oophorectomy). ...
Nine patients had stage I, 8 stage II, 11 stage III and 5 stage IV disease, whereas 3 patients had in situ carcinoma. A …
Use of autoantibodies to detect the onset of breast cancer.
Lacombe J, Mangé A, Solassol J. Lacombe J, et al. J Immunol Res. 2014;2014:574981. doi: 10.1155/2014/574981. Epub 2014 Jul 21. J Immunol Res. 2014. PMID: 25143958 Free PMC article. Review.
The widespread use of screening mammography has resulted in increased detection of early-stage breast disease, particularly for in situ carcinoma and early-stage breast cancer. However, the majority of women with abnormalities noted on screening mammograms ar …
The widespread use of screening mammography has resulted in increased detection of early-stage breast disease, particularly for in …
Are we overtreating intraductal papillomas?
Kiran S, Jeong YJ, Nelson ME, Ring A, Johnson MB, Sheth PA, Ma Y, Sener SF, Lang JE. Kiran S, et al. J Surg Res. 2018 Nov;231:387-394. doi: 10.1016/j.jss.2018.06.008. Epub 2018 Jun 29. J Surg Res. 2018. PMID: 30278958 Free PMC article.
In the absence of atypia on CNB, upgrade rates were 1.5% for invasive and 1.5% for in situ carcinoma. Personal history of breast cancer and magnetic resonance imaging-guided biopsy predicted for malignant upgrade. ...
In the absence of atypia on CNB, upgrade rates were 1.5% for invasive and 1.5% for in situ carcinoma. Personal history …
Predicting and Classifying Breast Cancer Using Machine Learning.
Alkhathlan L, Saudagar AKJ. Alkhathlan L, et al. J Comput Biol. 2022 Jun;29(6):497-514. doi: 10.1089/cmb.2021.0236. Epub 2021 Dec 9. J Comput Biol. 2022. PMID: 34883032
The malignant tumor category is divided into subsets of invasive carcinoma tumors and in situ carcinoma tumors. Furthermore, invasive carcinoma tumors are classified into grade 1, grade 2, or grade 3, where grade 3 is the highest and is more aggressive. ...
The malignant tumor category is divided into subsets of invasive carcinoma tumors and in situ carcinoma tumors. Further …
436 results